Featured

Top 100 Global Innovators for 2023 revealed [Report]

Ed White

Principal Analyst and VP

arrow_forward Read more
Biopharma
The Drugs to Watch in 2023
arrow_forward Read more
Academia and Government
Highly Cited Researchers 2022: Using deeper qualitative analysis to help spot research misconduct
arrow_forward Read more
Intellectual Property
December 11, 2017

When Two Become One: IP In The Age Of Mergers & Acquisitions
Life Sciences and Healthcare
December 8, 2017

How can pharma reps respect physicians’ time? We asked 20 doctors
Life Sciences and Healthcare
December 7, 2017

The latest plague outbreak in Sub-Saharan Africa
Intellectual Property
December 6, 2017

Healthy IP Asset Management – Time for a Software or Data Integrity Checkup?
Academia and Government
December 6, 2017

For Eun-Jung Park, a Long Road to “Highly Cited Researcher”
Life Sciences and Healthcare
December 5, 2017

The impact of the changing regulatory environment on the approval of new medicines, 2007-2016
Life Sciences and Healthcare
November 30, 2017

Green light to market Hemlibra for hemophilia A with inhibitors in the US
Life Sciences and Healthcare
November 29, 2017

Will an Effective Drug Ever Reach the Market for Geographic Atrophy?
Life Sciences and Healthcare
November 28, 2017

Notable mergers & acquisitions in the life sciences in Q3 2017
Academia and Government
November 28, 2017

New Fast-Breaking Paper in coral Reef Ecology
Life Sciences and Healthcare
November 28, 2017

Cultivating a well-trained revenue cycle workforce
Intellectual Property
November 27, 2017

TM go365™ goes head-to-head against the competition
Life Sciences and Healthcare
November 21, 2017

Notable licensing deals in the biopharma industry in Q3 2017
Academia and Government
November 20, 2017

What’s new in the ScholarOne Manuscripts v4.22 release
Life Sciences and Healthcare
November 16, 2017

For the tradition-bound biopharma industry, resisting change is no longer an option